Li Zhu

机构：Nanjing University of Chinese Medicine, Dalian Medical University, Second Affiliated Hospital of Dalian Medical University · ORCID：0000-0002-1302-7208

发表论文 65 篇 · 总被引 1840 次 · h-index 21

代表论文

• Amplification of anticancer efficacy by co-delivery of doxorubicin and lonidamine with extracellular vesicles (2022 · Drug Delivery · 被引 53)
• ZT-25, a new vacuolar H+-ATPase inhibitor, induces apoptosis and protective autophagy through ROS generation in HepG2 cells (2015 · European Journal of Pharmacology · 被引 49)
• CircCRIM1 Promotes Hepatocellular Carcinoma Proliferation and Angiogenesis by Sponging miR-378a-3p and Regulating SKP2 Expression (2021 · Frontiers in Cell and Developmental Biology · 被引 43)
• Inhibition of disheveled-2 resensitizes cisplatin-resistant lung cancer cells through down-regulating Wnt/β-catenin signaling (2016 · Experimental Cell Research · 被引 37)
• A silver-catalyzed radical ring-opening reaction of cyclopropanols with sulfonyl oxime ethers (2020 · Organic & Biomolecular Chemistry · 被引 26)
• Synthesis and Evaluation of Cleistanthin A Derivatives as Potent Vacuolar H + ‐ATPase Inhibitors (2015 · Chemical Biology & Drug Design · 被引 23)